Literature DB >> 17016016

[Induction of glutathione and activation of immune functions by low-dose, whole-body irradiation with gamma-rays].

Shuji Kojima1.   

Abstract

We first examined the relation between the induction of glutathione and immune functions in mice after low-dose gamma-ray irradiation. Thereafter, inhibition of tumor growth by radiation was confirmed in Ehrlich solid tumor (EST)-bearing mice. The total glutathione level of the splenocytes transiently increased soon after irradiation and reached a maximum at around 4 h postirradiation. Thereafter, the level reverted to the 0 h value by 24 h postirradiation. A significantly high splenocyte proliferative response was also recognized 4 h postirradiation. Natural killer (NK) activity was also increased significantly in a similar manner. The time at which the response reached the maximum coincided well with that of maximum total glutathione levels of the splenocytes in the gamma-ray-irradiated mice. Reduced glutathione exogenously added to splenocytes obtained from normal mice enhanced the proliferative response and NK activity in a dose-dependent manner. The inhibitory effects of radiation on tumor growth was then examined in EST-bearing mice. Repeated low-dose irradiation (0.5 Gy, four times, before and within an early time after inoculation) significantly delayed the tumor growth. Finally, the effect of single low-dose (0.5 Gy), whole-body gamma-ray irradiation on immune balance was examined to elucidate the mechanism underlying the antitumor immunity. The percentage of B cells in blood lymphocytes was selectively decreased after radiation, concomitant with an increase in that of the helper T cell population. The IFN-gamma level in splenocyte culture prepared from EST-bearing mice was significantly increased 48 h after radiation, although the level of IL-4 was unchanged. IL-12 secretion from macrophages was also enhanced by radiation. These results suggest that low-dose gamma-rays induce Th1 polarization and enhance the activities of tumoricidal effector cells, leading to an inhibition of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016016     DOI: 10.1248/yakushi.126.849

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  7 in total

1.  Efficacy of polysaccharide from Alcaligenes xylosoxidans MSA3 administration as protection against γ-radiation in female rats.

Authors:  Amal I Hassan; Mona A M Ghoneim; Manal G Mahmoud; Mohsen M S Asker; Saher S Mohamed
Journal:  J Radiat Res       Date:  2015-12-28       Impact factor: 2.724

2.  Treatment of Cancer and Inflammation With Low-Dose Ionizing Radiation: Three Case Reports.

Authors:  Shuji Kojima; Mitsutoshi Tsukimoto; Noriko Shimura; Hironobu Koga; Akishisa Murata; Tsuyoshi Takara
Journal:  Dose Response       Date:  2017-03-23       Impact factor: 2.658

Review 3.  Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications.

Authors:  Jiuwei Cui; Guozi Yang; Zhenyu Pan; Yuguang Zhao; Xinyue Liang; Wei Li; Lu Cai
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

4.  Role of ATP as a Key Signaling Molecule Mediating Radiation-Induced Biological Effects.

Authors:  Shuji Kojima; Yasuhiro Ohshima; Hiroko Nakatsukasa; Mitsutoshi Tsukimoto
Journal:  Dose Response       Date:  2017-02-15       Impact factor: 2.658

Review 5.  Effect of low-dose total-body radiotherapy on immune microenvironment.

Authors:  Zhuo Chen; Zhouxue Wu; Tobias Achu Muluh; Shaozhi Fu; Jingbo Wu
Journal:  Transl Oncol       Date:  2021-05-18       Impact factor: 4.243

6.  Assessment of Some Immune Parameters in Occupationally Exposed Nuclear Power Plant Workers: Flow Cytometry Measurements of T Lymphocyte Subpopulations and Immunoglobulin Determination.

Authors:  Ilona Mihaylova Gyuleva; Kalina Ivanova Penkova; Ivanka Tankova Rupova; Delyana Yonkova Panova; Jana Nikolaeva Djounova
Journal:  Dose Response       Date:  2015-11-17       Impact factor: 2.658

7.  The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial.

Authors:  Hongsheng Yu; Yong Qu; Qingjun Shang; Chao Yan; Peng Jiang; Xiang Wang; Donghai Liang; Tao Jiang
Journal:  Onco Targets Ther       Date:  2016-09-07       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.